Aug 2026· BMC Methods· Vol 3· 0 citations· 48 references
Medicine
TL;DR
An ex vivo co-culture protocol for modeling bone metastasis that enables direct investigation of cancer cell interactions with the native bone and marrow microenvironment and enables high-throughput functional interrogation of cancer colonization in a complex microenvironment is presented.
Abstract
One of the major challenges in late-stage cancer research is studying the direct interactions between cancer cells and the metastatic tissue. Metastasis is an inefficient multistep process in which only a small subset of cancer cells successfully colonizes the new microenvironment. Bone is the most common tissue for breast and prostate cancer metastasis and the third most common site across all cancer types. We present an ex vivo co-culture protocol for modeling bone metastasis that enables direct investigation of cancer cell interactions with the native bone and marrow microenvironment. The procedure involves the extraction and preparation of mouse long bones (femurs and tibiae), injection of cancer cells into the bone marrow cavity, maintenance of the co-culture, and sample processing for downstream analysis. The protocol supports functional readouts, including bioluminescence imaging of tumor cell viability, conditioned media sampling, and downstream tissue analysis, such as immunohistochemistry or micro-computed tomography (µCT). The culture setup procedure can be completed in a single day, and daily media maintenance thereafter requires minimal time. Final sample processing times vary, depending on the analysis completed. The system maintains viable and metabolically active bone, marrow, and cancer cells for up to four weeks and preserves the heterogeneity of the bone microenvironment. It is highly adaptable for various cancer types and bone genotypes and enables high-throughput functional interrogation of cancer colonization in a complex microenvironment. The protocol requires basic expertise in mammalian cell culture and mouse dissection and is suitable for researchers studying metastasis, tumor–stroma interactions, or preclinical therapeutic screening in the bone microenvironment. Not applicable.
This review summarizes the main preclinical models from spheroids to PDXs used to study OS and their ability to reproduce the tumor microenvironment, highlighting their importance for improving research and developing more effective therapies.
Giuseppe Di Feo, A. Di Paola, Oriana Di Domenico et al.· Cancers· 0 citations
Background Solid tumors account for the majority of cancer-associated morbidity, and the tumor microenvironment (TME) is a critical determinant of therapeutic response. However, the limited availability of optimized preclinical orthotopic cancer models that allow investigation of the TME constrains the development an...
Müge Özkan, I. Evcili, Bilgin Güngör· Open Research Europe· 0 citations
It is shown that breast cancer metastases differ in their capacity for secondary seeding: the liver fosters metastasis-promoting properties and boosts secondary spread, whereas the lung restricts these processes, favoring local growth.
Magdalena K. Sznurkowska, Francesc Castro-Giner, Irene D'Anna et al.· Cancer Discovery· 0 citations
Simple Summary The majority of cancer-related deaths result from metastatic disease rather than the primary tumor. Bone is the predominant site of distant metastasis in breast cancer and represents one of the greatest clinical challenges, affecting up to 70% of patients with advanced disease. Studies from several labor...
S. Mondal, Elizabeth Kenyon, B. Kim et al.· Cancers· 0 citations
The role of Siglec15 in tumor immunosuppression and osteolytic destruction was determined, and validated with recombinant Siglec15 antibody, and the results broaden the understanding of the immune-microenvironment of GCTB, and provide a new insight for reducing the recurrence by adjuvant therapy.